Seite drucken Druckansicht schließen
Logo Going International
Neue Suche | Kongressdetail
 

6th Obesity and NASH Drug Development Summit 2022

Evvnt Promotion / evvnt
Archiv
-
29.11.2022 - 01.12.2022  Revere Hotel Boston Common, 200 Stuart Street, 02116 Boston, Massachusetts, USA
Time: 09:55 - 16:40
 
Kongressthemen
The first wave of investment in NASH is dispersing in the wake of highly demanding biopsy endpoints, but opportunities to target obesity and metabolic syndrome are catalyzing increasing excitement. Pivotal readouts in GLP-1 receptor agonists and exciting progress in regenerative medicine and microRNAs are redefining the drug development landscape for metabolic disorders.
Kongressorganizer (PCO)
Hanson Wade
Anmerkungen
Brochure: https://go.evvnt.com/1277295-3?pid=4832

Speakers: Allison Goldfine, Director, Translational Medicine Cardiometabolic Disease, Novartis, Andrew Billin, Senior Director Biomarker Sciences, Gilead, and more.
 

Anfragen und Anmeldung:

https://go.evvnt.com/1277295-2?pid=4832
Frau Jessica Durston
 
Kategorien
Allgemeinmedizin
Sprache
Englisch
Kongressgeb├╝hr
USD 2599.00 - USD 5097.00
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Gro├čbritannien